NCT05497843 2025-04-03Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)Chipscreen Biosciences, Ltd.Phase 2 Completed40 enrolled
NCT05336721 2025-03-24A Phase II Study of Chiauranib in Combine With Capecitabine in TNBCChipscreen Biosciences, Ltd.Phase 2 Terminated9 enrolled